BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 7, 2007
View Archived Issues
Novel treatment options for cancer outlined in recent patent literature
Read More
New agents for psychopharmacologic disorders described in recent patents
Read More
Clera patent discloses novel imaging agents for Parkinson's disease
Read More
AstraZeneca announces second quarter 2007 results
Read More
Novavax initiates clinical trial for VLP-based influenza vaccine
Read More
Ovation begins clinical trial of i.v. carbamazepine for epilepsy
Read More
Valeant completes enrollment of first retigabine pivotal phase III study
Read More
Orphan drug designation of LX-211 recommended by EMEA committee
Read More
Mecamylamine augmentation for the treatment of depression
Read More
First-in-man study of a compound targeting CENP-E
Read More
Ovarian cancer vaccine stimulates immune response in a phase I trial
Read More
MacroGenics initiates three clinical trials with teplizumab in type 1 diabetes
Read More
Univ. Birmingham selects Eden Biodesign to develop and produce novel autoimmune disease drug
Read More
ORG-26576 enhanced AMPA receptor function and increased working memory in animal studies
Read More
Genta and Emisphere submit IND for oral G-4544 formulation
Read More
Tobira completes Series A financing and licenses rights to Takeda anti-HIV compounds
Read More
Nuvelo reduces workforce and readjusts development programs
Read More
Rosetta Genomics and Ben Gurion University to collaborate on microRNA-based applications
Read More
Advanced Cell Technology and Mytogen enter merger agreement
Read More
OncoGenex begins enrollment for OGX-427 phase I trial for cancer
Read More
Enzon enrolls patients in PEG-SN38 phase I study for solid tumors or lymphoma
Read More
MedImmune begins phase IIa trial of MEDI-528 for asthma
Read More
Rheoscience and Dr. Reddy's begin phase III study of balaglitazone
Read More
New HIV Tat vaccine induces humoral and cell-mediated immune responses in mice
Read More
Interim results show improved lipid profiles in HIV patients treated with boosted Invirase
Read More
FDA approves Indevus's Sanctura XR for once-daily treatment of OAB
Read More
Health Canada approves GW and Bayer's Sativex for cancer pain
Read More